ARCHIVES

Lilly Suspends Phase III Trial Of Tasisulam in Melanoma

This article is from The Cancer Letter archive.

Vol. 34 No. 1 | January 28, 2011

Download PDF Visit The Full Archive

Related Articles

NCI SBIR Offers $10 million in 10 Awards

February 18, 2011

Cooperative Groups: Insurer To Cover Patient Care Costs In Clinical Trials

December 4, 1998

Research Opportunities Growing, $$ Shrinking, Young Tells Congress

March 29, 1991

In Brief: Patent For Semisynthetic Taxol Issued To FL Scientist; Simone To Chair Pediatric Group

June 7, 1991

Centers May Become More specialized, Klausner Tells AACI

April 26, 1996

Progress Toward Year 2000 Goal Slow, But NCAB Says It’s Too Early, Only Data Up To ’87 Available

January 5, 1990